Kenvue's interim CEO Kirk Perry met Robert F. Kennedy Jr. to try and dissuade him from listing Tylenol as a potential cause ...

Tylenol-maker Kenvue Inc. spoke with Health Secretary Robert F. Kennedy Jr. in a bid to keep the over-the-counter painkiller ...

Kenvue interim CEO Kirk Perry met privately this week with RFK Jr. to argue that there is no proven link between Tylenol and ...

Kenvue (KVUE) stock is in focus as the company prepares a strong defense as an HHS report may link its Tylenol (acetaminophen ...

If you have been watching Kenvue (KVUE) lately, there is a good chance the news has caught your attention. A series of ...

The CEO of the company that makes Tylenol has directly pleaded with Robert F. Kennedy Jr. not to link the drug to autism.

Kenvue said it continues to review research and sees no evidence of causation. The company noted that the Food and Drug ...

RFK Jr. is preparing a report that will allegedly claim a link between prenatal Tylenol (acetaminophen) use and autism.

The interim CEO and director of drugmaker Kenvue, which makes the common pain reliever Tylenol, met with US Health and Human ...

In a hastily scheduled meeting, Kenvue interim Chief Executive Kirk Perry sought to dissuade the health secretary, arguing ...

Seeking Alpha's roundup of statements, announcements and remarks that could impact markets, sectors and individual stocks.